Airgraft Inc.

Airgraft in its $33 million Series B financing


Airgraft Inc.


$33 million


Emerging and High Growth Companies

Date Closed

Lead Office



On August 14, 2019, Airgraft Inc. announced a $33 million Series B financing round led by Gotham Green Partners and HumanCo. Airgraft will use this financing to drive innovation and consumer awareness as well as to support the launch of their new Clean Vaporizer.

Airgraft Inc. is a responsible vaporization technology company headquartered in Montreal, Canada that designs, develops, and sells vaporization hardware and software. Airgraft was founded in 2018 by a multinational team of designers, engineers, scientists and technologists with a rich history of global brand and product launches.

Osler, Hoskin & Harcourt LLP advised Airgraft Inc. with a team led by Shahir Guindi and consisting of Natasha Gould and Sarah Lazure (Corporate).